INGN's Business Model
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
| Sector & Industry | Healthcare / Medical - Devices |
| Website | https://www.inogen.com |
| CEO (Chief Executive Officer) | Kevin R. Smith |
| Number of Employees | |
| IPO date | February 14, 2014 |
INGN Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | US |
| Address | 301 Coromar Drive |
| City | Goleta |
| State | CA |
| Phone | 805 562 0500 |
| Zip Code | 93117 |
| Other Identifiers | |
| CIK | 0001294133 |
| ISIN | US45780L1044 |
| CUSIP | 45780L104 |
| Open | 7.38 |
| Previous Close | 7.22 |
| Volume | 126.3 Thou. |
| Average Volume | 173.7 Thou. |
| Day’s Range | 6.99 – 7.395 |
| 52 Week Range | 5.7-12.91 |
| MA (50) | 7.0214 |
| MA (200) | 7.2271 |
| Market Cap | 190.8 Mil. |
| Shares Out. | 27.15 Mil. |
| Earnings Date | Mar 03, 2026 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
Industry Competitors for INGN
|
Company
|
PE Ratio | Market Cap |
|---|---|---|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
